Osmotic dilators plus mifepristone or misoprostol for cervical preparation before dilation and evacuation between 18 0/7 and 21 6/7 weeks’ gestation: A retrospective cohort study
Abortion
Awarded 2020
Complex Family Planning Fellowship Research
Stephanie Lambert, MD
Planned Parenthood of Greater New York
$15,000

This retrospective cohort study aims to determine the effect of cervical preparation with osmotic dilators plus adjuvant overnight mifepristone compared to same-day misoprostol prior to dilation and evacuation between 18 0/7 and 21 6/7 weeks’ gestation on procedure time and other important clinical outcomes. Our sample size (n=574) will also allow greater numbers to describe important but uncommon secondary outcomes including acute complications to better contextualize the implications of these two cervical preparation strategies in practice.

Skip to toolbar